Skip to main content
. 2011 Mar 16;19(5). doi: 10.1038/ejhg.2011.27

Table 7. Example table: multivariate association between demographic, environmental and genetic risk factors and progression to advanced age-related macular degeneration (AMD).

  Regression coefficient (βi) OR (95% CI)a P
Intercept (α) −5.780    
Age (years)
 ≤70 0 1.0  
 >70 0.4116 1.5 (1.1–2.0) 0.008
       
Sex
 Female 0 1.0  
 Male 0.0688 1.1 (0.8–1.5) 0.68
       
Education
 ≤High school 0 1.0  
 >High school −0.1280 0.9 (0.6–1.2) 0.42
       
Baseline grade
 2 0 1.0  
 3 2.3944 11.0 (5.3–22.8) <0.001
 4 2.9521 19.1 (8.9–41.2) <0.001
       
Smoking
 Never 0 1.0  
 Past 0.1211 1.1 (0.8–1.6) 0.47
 Current 1.1261 3.1 (1.7–5.6) <0.001
       
BMI
 <25 0 1.0  
 25–29 0.5170 1.7 (1.2–2.4) 0.006
 30+ 0.4754 1.6 (1.1–2.4) 0.024
       
Treatment group
 Placebo 0 1.0  
 Antioxidants −0.1299 0.9 (0.6–1.3) 0.54
 Zinc −0.3897 0.7 (0.4–1.0) 0.075
 Antioxidants and zinc −0.4973 0.6 (0.4–0.9) 0.023
       
rs1061170
 TT 0 1.0  
 CT 0.2644 1.3 (0.8–2.1) 0.29
 CC 0.6778 2.0 (1.1–3.5) 0.019
P trend     0.014
       
rs10490924
 GG 0 1.00  
 GT 0.8396 2.3 (1.6–3.3) <0.001
 TT 1.3837 4.0 (2.6–6.1) <0.001
P trend     <0.001
       
rs1410996
 TT 0 1.0  
 CT 0.5251 1.7 (0.7–4.0) 0.23
 CC 0.8606 2.4 (1.0–5.8) 0.061
P trend     0.029
       
rs9332739
 GG 0 1.0  
 CG/CC −1.0510 0.4 (0.2–0.8) 0.010
       
rs641153
 CC 0 1.0  
 CT or TT −0.2147 0.8 (0.5–1.4) 0.42
       
rs2230199
 CC 0 1.0  
 CG 0.3679 1.4 (1.1–2.0) 0.022
 GG 0.5970 1.8 (1.0–3.2) 0.044
P trend     0.006

Adapted from ref. 6.

a

ORs adjusted for age (<70, ≥70), sex, education (≤high school, >high school), smoking (never, past, current), baseline AMD grade, BMI (<25, 25–29, 30+) and treatment groups (placebo, antioxidants, zinc and antioxidants plus zinc), and all six genetic variants and associated genotypes as listed in the table. Calculation of the AMD progression risk Score=α+βiXi, where i refers to each of the variables listed.